chrisvoncsefalvay/vaers-outcomes huggingface dataset:
02/1/2022 I had congestion and cough. I went to a clinic. My COVID-19 test was negative. A couple days later, I went to the doctor, and he gave me an antibiotic, steroid and inhaler. I was diagnosed with bronchitis. He also gave me a cough medicine with codeine which helped with the cough. The next day I lost my sense of smell and taste again. I did not feel any better after the medications. After a few weeks I got through it. After 3 weeks, my taste and smell came back, but was a distorted kind of taste and smell. I can tell sweet, salty and strong flavors. Some food taste really bad and I am unable to enjoy certain foods. Besides that, everything is good.
Patient came to pharmacy on 7/26/19 with her husband stating that her arm has been throbbing after she had received the vaccine.  Advised patient to alternate cold/heat but more heat and if needed to take tylenol.  Also advised patient if her symptoms get worse or if pain is spreading to go to ER.  Followed up with patient the next day and she said heat has been helping a lot.  Will contact her primary care physician on Monday to inform him of the incident.
Pfizer-BioNTech COVID-19 Vaccine EUA Symptoms experienced: Lightheaded, shortness of breath with hyperventilation. She was laying on the floor and appeared shaky with red blotching on face and neck. Actions taken: Medical Response called.  Anaphylaxis Medication given epinephrine (adult) IM outer thigh. Patient was placed on stretcher and taken to ER.  Patient also received diphenhydramine and famotidine in ER.
patient called reported her arm got swollen, and she went to the er and they diagnosed her with cellulitis. according to her the doctor think it is related to the vaccine
At the medical facility, within minutes of taken the shot, my left eye vision started to get blurry. I started to sweat. Medical personnel took my blood pressure and said it was high. They had me rest on a bed for 10 minutes. They gave me water and juice.  After 2 days of the vaccine, I feel strange heart palpitations every 1 or 2 hours. My blood pressure reading is at 147/88.
A report has been received from a Health Professional concerning a 14 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 02-Dec-2013. The patient experienced administration of expired product which started on 02-Dec-2013. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious by the reporter.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, drug reactions and allergies were not reported. On 07-FEB-2019, the patient was vaccinated with VARIVAX (strength, dose, anatomical location, and route of administration were not reported) lot # R019237 with expiration date of 04-JUL-2020, indicated for prophylaxis; which was reconstituted with sterile diluent (MERCK) properly stored. Administered dose of the vaccine experienced a temperature excursion of 6 degrees Fahrenheit (F°) to 14 degrees Fahrenheit (F°) (9.9 (F°)) for 5 minutes on unspecified date, which was recorded with a data logger. There were no previous excursions reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1902USA003926.
vesicular outbreak, which was diagnosed as severe herpes zoster or shingles; The vaccine did not prevent shingles as intended; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant medication use were not provided.   On or about 03-OCT-2012, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, strength, administration route, anatomical location, lot number and expiration date were not reported) for routine adult health maintenance and for the long-term prevention of shingles at a pharmacy.The reporter stated that the vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later on or about 12-SEP-2014, the patient was treated for the onset of a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles. The patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages.
got at hospital because she was sick with Covid; got at hospital because she was sick with Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Nov2022 as dose 4 (booster), single (Lot number: GH9697) for covid-19 immunisation; BNT162b2 (BNT162B2), on 17Mar2021 as dose 1, single (Lot number: EN6207), on 08Apr2021 as dose 2, single (Lot number: EW0151) and on 03May2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Had Lyme a few years ago" (unspecified if ongoing); "ehrlichiosis, a tick disease" (unspecified if ongoing), notes: Had 2 tick disease 3 years ago, she is negative now, but she wonders; "Did affect her memory a little bit" (unspecified if ongoing), notes: Did affect her memory a little bit; "shingles" (unspecified if ongoing); "chicken pox" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN; HYDROXYCHLOROQUINE. The following information was reported: VACCINATION FAILURE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "not recovered" and all described as "got at hospital because she was sick with Covid". The event "got at hospital because she was sick with covid" required physician office visit. The patient underwent the following laboratory tests and procedures: Body temperature: (20Aug2023) 101.5, notes: Last night fever 101.5; (21Aug2023) 100, notes: Today fever is about 100; SARS-CoV-2 test: (unspecified date) Positive, notes: She tested the next morning and tested positive; (20Aug2023) Positive, notes: Unit: Not Provided; Weight: (unspecified date) 92 and a half pounds. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: The patient's height was reported to be about 5 foot. The lot number for the 3rd Pfizer Covid vaccine looked like FM or FN 992Z. It's handwritten and the patient can't tell.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax 27OCT95 & 24hr p/vax pt exp flu-like sx, fever & asthmatic attack, malaise, achiness;ER or MD visit was required & pt was hosp in NOV x 5 days;
Within 10 minutes following the second vaccination, patient reported dizziness and nausea, had an episode of vomiting but recovered within 30 minutes.  It was reported to our clinic that the patient was found deceased on March 1, 2021 at approximately 10 pm.  Cause of death is not determined at this time.
Hives and low grade temp (99), muscle aches, pain at injection site with redness/swelling. hives resolved quickly with oral benadryl. pain and redness/swelling gradually improved over 1 week's time.
Report A0363801A describes muscle pain in a 51 year old male who received Lyme disease vacicne recombiannt. This report was received from the vaccinee's wife and has not been verified by a physician or other healthcare professional. Medical history and concurrent conditions reportedly included tendonitis (treated with Celebrex) and elevated cholesterol (treated with Lipitor for 8 to 10 years). Additional concurrent medications reportedly included multivitamin, fish oil, and vitamin E. in September 2001, the vaccinee reportedly received his first injectin of LYMERix without adverse event. "Seven weeks later," the vaccinee received his second injection of LYMErix. It was reported that beginning in January or February 2002, he began to experience arm and leg muscle pain. He reportedly received no treatment for these events. As of 3/12/02, the vaccinee's muscle pain was reportedly ongoing.
Information has been received from a pharmacist concerning an 80 year old female with hypertension and no allergies who on 08-JUN-2007 was vaccinated with a single dose of Zostavax (Oka/Merck).  Concomitant therapy included atenolol, hydrochlorothiazide and aspirin.  It was reported that on 26-JUN-2007 the patient developed herpes zoster like rash on her abdomen.  The patient had developed vesicles on her arm on 04-JUN-2007, prior to vaccination.  The details about the rash and it's location were unknown.  The patient was treated with VALTREX on 27-JUN-2007.  No diagnostic laboratory tests were undertaken.  At the time of report the patient had not recovered.  Additional information has been requested.
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. No concurrent condition, medical history or concomitant therapy was provided. On 29-JAN-2016, the patient were vaccinated with an improperly stored dose of VARIVAX (Merck) (lot # L025209 and expiration date 07-JUL-2017, dose and route not reported), which was stored under 10.1 F for 1 hour and 57 minutes. The previous temperature excursion was reported as 13.7 F for 61 hours and 38 minutes, 14.8 F for 20 hours and 33 minutes, and Cumulative excursion was reported as 13.7 F for 63 hours and 35 minutes, 14.8 F for 20 hours and 33 minutes. No adverse effects were reported. All telephone attempts to obtain follow up information had been unsuccessful. This is one of several reports received from the same reporter. Additional information has been requested.
Narrative: A 32yo B. female with PMH of Cardiac murmur and anxiety disorder She was reported with Pfizer Covid -19 vaccine induced ADR ofN/V, on April 14, 2021, by the unit's PA Per nurse's documentation- she received Pfizer's Covid - 19 vaccine 1M in the LT deltoid without complication, per policy and protocol, on April 9, 2021 On April 14, 2021 she presented to the ER with nausea and vomiting x 2 days post Covid- 19 vaccine Per ER documentation, she was rehydrated and treated with I L ofD51/2NS, IL NS iv fluid, 4mg of ondansetron iv and 15mg of ketorolac iv Her discharge instructions included f/u with her primary and hydration with fluid and electrolytes, She was also informed PACT nurse would contact her within 48hrs The patient received second Pfizer Covid -19 vaccine on April 30 , 2021 to LT Deltoid 1M per policy and protocol and without complication.
Low grade fever, headache,  body ache, where I have arthritis pain was intensified and unbearable, somewhat lightheaded, vision slightly blurred-felt like I was in a tunnel, very tired and couldn?t sleep .  I had control of my arthritis and as of today (3/6/21) 16 days after shot it is mostly painful, 7 out of 10.  Mild lingering headache, and have trouble sleeping.
By 7 AM after vaccination date, arm extremely sore, with large red swelling around injection site (about 1.5 inches wide vertically, two inches high horizontally, and raised a few millimeters). Low-grade fever, chills. Treated with ibuprofen with some relief. But now, 6 PM, fever returning, and experiencing facial swelling.
This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number TM449, expiry date 02-JUN-2023) for prophylaxis.   On 30-JUN-2023, the patient received the 1st dose of Shingrix. On 30-JUN-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: expired dose of Shingrix (1st dose) administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 30-JUN-2023 The reporter consented to follow up. The reporter reported that an expired dose of Shingrix administered, which led to expired vaccine used.
I went in on whatever day that was they gave me shot, and I started feeling light headed. My husband had to drive home, I started feeling faint, I didn't eat or drink I just sleep including the following day. Then following the week, I started to notice the injection shot got red, it was the size of a penny and it grew to the side of a baseball I could not sleep on that side. I went to the doctor after a week and a half, it was covering from the top of my shoulder to my elbow. When I got the injection I felt this cold injection go into my face and into my arm and I felt numb and it went down left side of my body. I had this passive spot that was red and hot to the touch and the doctor told me that I had COVID arm and that it should only last for a week it was very painful to move. And he stated that it should only last only a week, and I cant remember if it lasted a week or 2. I ask the doctor if I should the second shot of Moderna or switch and he didn't know because there is not enough information, the doctor told me to get it and just make sure I was close to a doctor. I also blood placements, so I am an easier bleeder.
pt devel high fever & devel gen sz activity & was brought for eval;pt recv LP & blood work was obtained;
1503: Patient returns to area, mom lifts atient?s shirt to reveal hives on back and front of trunk, neck, and on upper arms. Pt also noted to be scratching. Patient AAO, respirations even/unlabored at 20/min, patient is calm with no s/s of distress.   1505: Area cleared, Vital signs taken, initiated close monitoring and observation for safety. 1508: Administered Benadryl 25mg chewable tablet PO 1511: Language line called, explained to mother that hives are an allergic reaction, that the patient is not in immediate danger or distress, and explained the medication administered and how it should help 1517: Vital signs taken and pt reassessed. Hives still visible, but no s/s of distress or increase in severity. Close monitoring continued. 1520: Notified Dr. of situation via phone, MD orders taken: 1. Follow procedures for moderate allergic reaction 2. Continue monitoring for 30 minutes, then evaluate ensure reaction is not progressing in severity. 1524: Onsite provider NP comes to area, evaluates patient. NP reinforces that patient is experiencing a mild reaction, and that it is safe for patient to leave clinic as reaction is not progressing in severity. 1529: Patient reassessed. Fewer hives visible, and those seen are noted to be smaller and less raised. Close monitoring continued. 1537: Program manager contacted via phone and briefed on situation. 1545: Spoke with parent again via language line iinterpreter.Educated parent on hives as an allergic reaction, medication given as treatment, s/s of anaphylaxis, and instructed to seek emergency medical care if symptoms worsen. Parent verbalized understanding. 1550: Reinforced instructions to parent to seek emergency care if condition worsens. Assessment reveals hives visibly reduced, no s/s of discomfort or distress. 1551: Patient left clinic in stable condition.
Initial report was received 17 June 2010 via a lay press publication from dated 16 June 2010 which involved six patients in the same geographical area who had been diagnosed with pertussis after they had received five previous DTaP vaccinations (lot number not reported). The information contained in the lay press publication had been retrieved from an immediate publication news released posted by a County Health and Human Services Agency (HHSA) on 16 June 2010. A copy of this HHSA news release was retrieved on 17 June 2010. This case represents one of the six reported patients. The other patients are captured in case numbers 2010-03433, 2010-03434, 2010-03435, 2010-03437 and 2010-03438. A 12-year-old patient (gender not reported) had received five prior doses of DTaP vaccine (manufacturers, lot numbers, routes, sites and dates of administration not reported) and an unspecified amount of time after receiving their fifth dose of DTaP vaccination, the patient was diagnosed with pertussis. This patient was one out of six local children who had been diagnosed with pertussis. Outcome was not reported. No additional information was provided at the time of the report. Documents held by sender: New Release.
She denied further AE; Patients were administered MMRII that underwent multiple temperature excursion since 12-MAY-2020; This spontaneous report was received from a registered nurse concerning an unreported age and gender patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, and previous drug reactions or allergies.  On 12-OCT-2020, the patient was vaccinated with 0.5 milliliters (ml) of improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) as prophylaxis (lot number S028916, expiration date 16-SEP-2021, which was determined to be valid) (formulation, dose number, vaccination scheme frequency, route and anatomical location of administration were not reported) (product storage error).   The involved vaccine underwent multiple temperature excursions; the warmest reported temperature was 21.6 grades Celsius (C) for a cumulative time of 15 hours and 30 minutes, as recorded by a data logger. No additional adverse events (AE) were reported.  This is one of 14 reports received from the same reporter.; Sender's Comments:  US-009507513-2107USA008497: US-009507513-2108USA000262: US-009507513-2108USA000271: US-009507513-2108USA000265: US-009507513-2108USA000266: US-009507513-2108USA000267: US-009507513-2108USA000268: US-009507513-2108USA000269: US-009507513-2108USA000270: US-009507513-2108USA000261: US-009507513-2108USA000260: US-009507513-2108USA000263: US-009507513-2108USA000259:
Feels like she is coming down with a cold; This is a spontaneous report received from a contactable reporter.  The reporter is the patient.  A 61 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "unknown", described as "Feels like she is coming down with a cold".  Additional information: She stated that she took the first dose and is now waiting for second dose of the vaccine and she stated she feels as if she coming down with a cold. She wonders is it okay to take  the second dose or should she wait.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 4/12/2023 ACUTE NON ST ELEVATION MI I82.412 ACUTE DVT OF LEFT FEMORAL VEIN 4/12/2023 ACUTE NON ST ELEVATION MI
Site: Pain at Injection Site-Medium, Additional Details: pt recieved covid vaccine today...verified location of the shot and it is right in the right deltoid of the right arm. pt immidiately after felt pain at the injection site that radiates to her hand. it has persisted for at least 30 minutes while we monitored pt in store. pt says its hard to hold things because of pain by forearm. referred pt to see primary care to see if any additional treatment is needed
Raised blister-like reaction approximately 1cm away from the injection site and under the bandaid.
9-19-18 approx. 2 pm mother brought patient in for immunization. Dtap was given in the left deltoid muscle using sterile 25GA1" syringe-(mother states nurse did clean arm well with alcohol swab) dried with cotton ball and spot Band-Aid applied. 9-20-18- patient noted arm swelling, redness induration and warmth - worse 9-21-18 around 6 am-mother took patient to health clinic and saw clinician states she thought it was either local reaction or cellulitis. (Mother states no fever).
Approximately 3-4 weeks after my 1st dose I experienced the following symptoms: Palpitations, Heart out of rhythm. I did not take any medication. It lasted for about a week and I went to an urgent care for consultation. The doctor thought it was COVID but tested negative and they said it might've been anxiety and to go and follow up with my primary care. The symptom went away a day after my visit to the urgent care.
difficulty swallowing after 1st dose; Sores in throat; This spontaneous case was reported by a pharmacist and describes the occurrence of DYSPHAGIA (difficulty swallowing after 1st dose) and OROPHARYNGEAL PAIN (Sores in throat) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included VALPROATE SEMISODIUM (DEPAKOTE), ATORVASTATIN and HYDROXYZINE for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced DYSPHAGIA (difficulty swallowing after 1st dose) and OROPHARYNGEAL PAIN (Sores in throat). At the time of the report, DYSPHAGIA (difficulty swallowing after 1st dose) and OROPHARYNGEAL PAIN (Sores in throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Rash on upper chest, itching. Given benadryl 50 mg PO. Observed. Cleared for home with plan for allergy f/u and continue zyrtec daily.
Appendicitis The evening after receiving second shot on 3/31 I started to experience abdominal pain.  Abdominal pain continued for 3 weeks.  I went to an urgent care facility on 3/19 due to increased pain levels and fever (101 F).  A CT scan indicated that I had acute appendicitis and acting MD advised me to go to emergency room.  I was admitted to hospital for 5 days (4/19~4/23).  Currently awaiting follow up to perform laparoscopic appendectomy.
reaction to the flu shot; Initial information received on 03-Dec-2020 regarding an unsolicited valid non-serious case received social media case through agency reported by a consumer (patient).  This case involves patient (unknown demographics) who had reaction to the flu shot (Vaccination complication), while the patient received vaccine influenza vaccine.  The patient's medical history, past medical treatment(s), vaccination(s), family history and concurrent conditions were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, (latency unknown) after initiation of suspect vaccine, the patient   had reaction to the flu shot (Vaccination complication).   No relevant laboratory data was reported.  It was unknown if the patient received a corrective treatment. The events outcome was unknown.  Author/Reporter comment:  Product Name: Product name was not provided. Since this is a public post on the Sanofi flu shot campaign we are assuming the consumer is referring to the Sanofi flu vaccine.  There will be no information available on the batch number for this case.